Anti-transglutaminase, antigladin and ultra purified anti-gladin antibodies in patients with a diagnosis of rheumatoid arthritis

被引:4
|
作者
Dionisio Castillo-Ortiz, Jose [1 ]
Duran-Barragan, Sergio [2 ]
Sanchez-Ortiz, Adriana [1 ]
Ramos-Remus, Cesar [2 ,3 ]
机构
[1] UMAE, Hosp Especialidades, Ctr Med Nacl Occidente, Inst Mexicano Seguro Social, Guadalajara, Mexico
[2] Unidad Invest Enfermedades Cron Degenerat, Guadalajara, Mexico
[3] Hosp Gen Reg 45, Inst Mexicano Seguro Social, Guadalajara, Mexico
来源
REUMATOLOGIA CLINICA | 2011年 / 7卷 / 01期
关键词
Rheumatoid arthritis; Celiac disease; Anti-tissue transglutaminase; Anti-gliadin and ultra purified anti-gliadin antibodies;
D O I
10.1016/j.reuma.2010.03.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Celiac disease (CD) is an enteric disease caused by dietary gluten in individuals with genetic predisposition. One of the clinical manifestations of CD is the peripheral arthritis that may simulate RA. Objective: To determine the frequency of anti-gliadin (aGL), anti-tissue transglutaminase (aTGT) and ultra purified anti-gliadin (AGLU) antibodies in patients with RA. Methods: Cross-sectional study. We included consecutive patients diagnosed as RA (ACR). Demographic and clinical data was registered by direct interview and serum levels of aGL, aTGT y aGLU were detrmined using ELISA. Results: Eighty-five RA patients were included; 87% were women. Mean age was 44+/-12 years, mean disease duration 12 +/-9 years. aGL IgG antibodies were positive in 16 patients, IgA aGL antibodies in 29 patients, aGLU in 14 patients and only one patient had aTGT. Conclusions: It is possible that CD may be the correct diagnosis in a patient with polyarthritis, even if the patient meets the ACR criteria for RA. In other words, CD should be considered among the differential diagnoses in a patient with poly-arthritis. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:27 / 29
页数:3
相关论文
共 50 条
  • [41] Comparison of six human anti-transglutaminase ELISAS in the diagnosis of Celiac disease in Sararawi population
    Fernández, E
    Riestra, S
    Blanco, C
    López-Larrea, C
    López-Vázquez, A
    Fuentes, D
    Moreno, M
    Rodrigo, L
    CLINICA CHIMICA ACTA, 2005, 355 : S131 - S131
  • [42] The role of salivary anti-transglutaminase autoantibodies at the diagnosis and follow-up of coeliac disease
    Nenna, R
    Tiberti, C
    Mura, S
    Ferri, M
    Thanasi, E
    Luparia, R
    Castronovo, A
    Fiore, B
    Verrienti, A
    Bonamico, M
    PEDIATRIC RESEARCH, 2005, 58 (02) : 399 - 399
  • [43] Rheumatoid arthritis and anti-thyroid antibodies
    Yavasoglu, Irfan
    Senturk, Taskin
    Coskun, Adil
    Bolaman, Zahit
    AUTOIMMUNITY, 2009, 42 (02) : 168 - 169
  • [44] Anti-BIP antibodies in rheumatoid arthritis
    Panayi, GS
    Bodman-Smith, M
    Corrigall, V
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 : S6 - S6
  • [45] ANTI-NUCLEAR ANTIBODIES AND RHEUMATOID ARTHRITIS
    ROQUES, CF
    SMILOVICI, W
    OKSMAN, F
    AMIGUES, H
    FOURNIE, A
    RUFFIE, R
    REVUE DE MEDECINE DE TOULOUSE, 1977, 13 (02): : 93 - 98
  • [46] Rheumatoid arthritis and anti-endomysial antibodies
    Nisihara, Renato Mitsunori
    Skare, Thelma L.
    Silva, Marilia Barreto
    Utiyama, Shirley Ramos da Rosa
    ACTA REUMATOLOGICA PORTUGUESA, 2007, 32 (02): : 163 - 167
  • [47] Anti-Ro Antibodies in Rheumatoid Arthritis
    Zanlorenzi, Lais
    Azevedo, Paula de Oliveira
    Silva, Marilia Barreto
    Skare, Thelma
    ACTA REUMATOLOGICA PORTUGUESA, 2012, 37 (02): : 149 - 152
  • [48] ANTI-NUCLEAR ANTIBODIES AND RHEUMATOID ARTHRITIS
    ROQUES, CF
    SMILOVICI, W
    OKSMAN, F
    AMIGUES, H
    FOURNIE, A
    RUFFIE, R
    REVUE DE MEDECINE DE TOULOUSE, 1977, 13 (03): : 179 - 184
  • [49] Anti-BIP antibodies in rheumatoid arthritis
    GS Panayi
    M Bodman-Smith
    V Corrigall
    Arthritis Res Ther, 5 (Suppl 1):
  • [50] The role of anti-citrullinated peptide antibodies in the diagnosis and management of rheumatoid arthritis
    Wilson, G.
    IMMUNOLOGY, 2011, 135 : 32 - 32